BCA
MRNA icon

Bay Colony Advisors’s Moderna MRNA Stock Holding History

Bay Colony Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,691
Closed -$287K – 442
2024
Q1 		$287K Buy
2,691
+232
+9% +$23.4K 0.05% 293
2023
Q4 		$245K Buy
2,459
+151
+7% +$12.7K 0.05% 308
2023
Q3 		$238K Sell
2,308
-293
-11% -$32.7K 0.06% 280
2023
Q2 		$316K Sell
2,601
-352
-12% -$47K 0.08% 227
2023
Q1 		$435K Buy
2,953
+99
+3% +$16.3K 0.11% 178
2022
Q4 		$513K Buy
2,854
+71
+3% +$11.6K 0.14% 156
2022
Q3 		$329K Buy
2,783
+50
+2% +$7.59K 0.1% 205
2022
Q2 		$448K Buy
2,733
+209
+8% +$29.9K 0.11% 176
2022
Q1 		$435K Buy
2,524
+1,567
+164% +$264K 0.1% 191
2021
Q4 		$243K Buy
957
+118
+14% +$34.5K 0.07% 301
2021
Q3 		$323K Sell
839
-390
-32% -$144K 0.11% 234
2021
Q2 		$289K Buy
+1,229
New +$220K 0.1% 262

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bay Colony Advisors's MRNA Position: Q2 2024 in Review

Bay Colony Advisors sold out of Moderna (MRNA) in Q2 2024, closing a stake of 2,691 shares — an estimated $287K sold.

Bay Colony Advisors first reported a position in MRNA in Q2 2021 and held it in 12 quarters. The position peaked at $513K in Q4 2022. 954 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Bay Colony Advisors reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Bay Colony Advisors sold 2,691 Moderna shares in Q2 2024, an estimated $287K.
  • Bay Colony Advisors first reported a position in Moderna in Q2 2021 and held it in 12 quarters.
  • Bay Colony Advisors's Moderna position peaked at $513K in Q4 2022.
  • 954 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Bay Colony Advisors's 13F filing for Q2 2024, filed 24 Jul 2024.